USPTO serial 97650292
NEREUS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 3, 2024
- Examiner
- KLUWE, CHERYL D
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NEREUS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Comberton, Cambridge, GB
Comberton, Cambridge, GB
Comberton, Cambridge, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ben Natter
Ben Natter HAUG PARTNERS, LLP745 FIFTH AVENUENEW YORK, NY 10151United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Nanofiber filtering compositions for protein, nucleic acid, viral particle extracellular vesicle and advanced therapeutic medicinal product purification; nanofiber filtering materials for protein, nucleic acid, viral particle, extracellular vesicle and advanced therapeutic medicinal product purification; biochemical and chemical preparation material for chromatographic purification of chemical and biological substances other than for medical or veterinary purposes; biochemical and chemical preparation substrates for chromatographic purification of substances comprising of chemicals and biologicals other than for medical or veterinary purposes; chemical and biological absorbents and adsorbents for recovery of viral particles and nucleic acids for development of viral vectors, extracellular vesicles and advanced therapeutic medicinal products; chemical and biological purifying agents for chromatographic purification of chemical and biological preparations other than for medical or veterinary purposes; chemicals and biologicals for use in bioseparation for protein purification, nucleic acid purification, viral particle purification extracellular vesicle purification and purification of advanced therapeutic medicinal products; chemicals and biologicals for use in filtering of proteins, nucleic acids, viral particles, extracellular vesicles and advanced therapeutic medicinal products; chemical and biological substances for use in separation for protein purification, nucleic acid purification, viral particle purification, extracellular vesicle purification and purification of advanced therapeutic medicinal product; fibres of inorganic material for separation purposes for viral particle purification; fibres of organic material for separation purposes for protein, nucleic acid, viral particle, extracellular vesicle and advanced therapeutic medicinal product purification; raw proteins for scientific and medical research; proteins for scientific and industrial use; enzymes for scientific and industrial use, reagents for scientific and research use other than for medical use; ligands for scientific and research use; biochemical, namely, antibodies and antibody fragments for in vitro scientific or research use. | ACTIVE | — |
| 005 | Proteins for medical diagnostic purposes; enzymes for medical use; nucleic acids for medical use; extracellular vesicles for medical use; advanced therapeutic medicinal products for medical use; proteins, namely nucleic acids for medical use; proteins, namely extracellular vesicles for medical use; proteins, namely advanced therapeutic medicinal products for medical use; medical and clinical diagnostic reagents; insulin and insulin analogues biochemical and chemical preparation material for chromatographic purification of chemical and biological substances, for medical or veterinary purposes; biochemical and chemical preparation substrates for chromatographic purification of substances comprising of chemicals and biologicals, for medical or veterinary purposes; chemical and biological purifying agents for chromatographic purification of chemical and biological preparations, for medical or veterinary purposes. | ACTIVE | — |
| 009 | Scientific research and laboratory apparatus, namely, laboratory filters for protein, nucleic acid, viral particle, extracellular vesicle and advanced therapeutic medicinal product purification; scientific purification apparatus, namely, laboratory filters used for protein, nucleic acid, viral particle extracellular vesicle and advanced therapeutic medicinal product purification; laboratory filters and purifiers for protein, nucleic acid, viral particle, extracellular vesicle and advanced therapeutic medicinal product purification; filtering and separation apparatus for protein, nucleic acid, viral particle extracellular vesicle and advanced therapeutic medicinal product purification; apparatus for bioseparation for protein, nucleic acid, viral particle extracellular vesicle and advanced therapeutic medicinal product purification; membranes and nanofibers for filtration for laboratory use; separation columns and separation devices for scientific purposes; bioprocessing columns for scientific purposes; chromatography apparatus and instruments for scientific purposes; temperature, pressure and optical sensors for bioprocessing apparatus and equipment. | ACTIVE | — |
| 010 | Diagnostic, examination and monitoring equipment, namely, medical diagnostic apparatus for filtering and testing of proteins, nucleic acids, viral particles and extracellular vesicles; purification apparatus for filtering and testing of proteins, nucleic acids, viral particles extracellular vesicle and advanced therapeutic medicinal product for medical purposes; filtering and separation apparatus for filtering and testing of proteins, nucleic acids, viral particles, extracellular vesicles and advanced therapeutic medicinal products for medical purposes; medical and veterinary apparatus for bioseparation, namely, protein, nucleic acid, viral particle and extracellular vesicle separation apparatus; membranes and nanofibres for filtration being filters for medical purposes, namely, protein, nucleic acid, viral particle and extracellular vesicle filters; separation instruments for medical use being filters for medical purposes, namely, protein, nucleic acid, viral particle and extracellular vesicle filters. | ACTIVE | — |
| 024 | Composite electrospun nanofiber material for use in protein, nucleic acid, viral particle, extracellular vesicle and advanced therapeutic medicinal product filtration; composite electrospun nanofibre textiles for use in protein, nucleic acid, viral particle, extracellular vesicle and advanced therapeutic medicinal product filtration; composite electrospun nanofiber filtering cloth for use in protein, nucleic acid, viral particle, extracellular vesicle and advanced therapeutic medicinal product filtration and purification. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ASTREA UK SERVICES LIMITED
- Other trademarks owned by ASTREA UK SERVICES LIMITED
- Other trademarks owned by ASTREA UK SERVICES LIMITED
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 024
- Similar marks named NEREUS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 3, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 3, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 1, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 1, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 11, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 22, 2024 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Aug 21, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 16, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Apr 16, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Apr 16, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 16, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 16, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 30, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 30, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 30, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 16, 2023 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Oct 16, 2023 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Oct 13, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 13, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 13, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 17, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 17, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 17, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 24, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 10, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 31, 2022 | NWAP | NEW APPLICATION ENTERED | — |